329 related articles for article (PubMed ID: 17999872)
1. Aliskiren: the first direct renin inhibitor for hypertension.
van den Meiracker AH; Jan Danser AH
Curr Cardiol Rep; 2007 Nov; 9(6):470-6. PubMed ID: 17999872
[TBL] [Abstract][Full Text] [Related]
2. Greater reductions in plasma aldosterone with aliskiren in hypertensive patients with higher soluble (Pro)renin receptor level.
Bokuda K; Morimoto S; Seki Y; Yatabe M; Watanabe D; Yatabe J; Ando T; Shimizu S; Itoh H; Ichihara A
Hypertens Res; 2018 Jun; 41(6):435-443. PubMed ID: 29618841
[TBL] [Abstract][Full Text] [Related]
3. Now that we have a direct renin inhibitor, what should we do with it?
Stanton A
Curr Hypertens Rep; 2008 Jun; 10(3):194-200. PubMed ID: 18765089
[TBL] [Abstract][Full Text] [Related]
4. Novel drugs targeting hypertension: renin inhibitors.
Danser AH
J Cardiovasc Pharmacol; 2007 Aug; 50(2):105-11. PubMed ID: 17703126
[TBL] [Abstract][Full Text] [Related]
5. [Renin as a target of direct pharmacological block in arterial hypertension].
Mukhin NA; Fomin VV
Ter Arkh; 2009; 81(8):5-9. PubMed ID: 19799192
[TBL] [Abstract][Full Text] [Related]
6. Aliskiren, the future of renin-angiotensin system blockade?
Uresin Y; Mehtar Bozkurt M; Sabirli S; Ozunal ZG
Expert Rev Cardiovasc Ther; 2007 Sep; 5(5):835-49. PubMed ID: 17867914
[TBL] [Abstract][Full Text] [Related]
7. The renin angiotensin system in the development of cardiovascular disease: role of aliskiren in risk reduction.
Verdecchia P; Angeli F; Mazzotta G; Gentile G; Reboldi G
Vasc Health Risk Manag; 2008; 4(5):971-81. PubMed ID: 19183745
[TBL] [Abstract][Full Text] [Related]
8. [Does the rennin inhibitor aliskiren offer promising novel opportunities in the treatment of cardiovascular diseases?].
Horký K
Vnitr Lek; 2007 Apr; 53(4):364-70. PubMed ID: 17578167
[TBL] [Abstract][Full Text] [Related]
9. Potential benefits of aliskiren beyond blood pressure reduction.
Weintraub HS; Tran H; Schwartzbard A
Cardiol Rev; 2011; 19(2):90-4. PubMed ID: 21285669
[TBL] [Abstract][Full Text] [Related]
10. Direct renin inhibition--commonly asked questions.
Sica DA
J Clin Hypertens (Greenwich); 2008 Nov; 10(11):871-5. PubMed ID: 19128278
[No Abstract] [Full Text] [Related]
11. The development of the direct renin inhibitor aliskiren: treating hypertension and beyond.
Siragy H; Huang J; Lieb DC
Expert Opin Emerg Drugs; 2008 Sep; 13(3):417-30. PubMed ID: 18764720
[TBL] [Abstract][Full Text] [Related]
12. Renin inhibition with aliskiren: where are we now, and where are we going?
Azizi M; Webb R; Nussberger J; Hollenberg NK
J Hypertens; 2006 Feb; 24(2):243-56. PubMed ID: 16508564
[TBL] [Abstract][Full Text] [Related]
13. The renin inhibitor aliskiren as novel treatment for cardiovascular disease.
Saez AO; Philipp T; Nürnberger J
Recent Pat Cardiovasc Drug Discov; 2006 Nov; 1(3):233-40. PubMed ID: 18221088
[TBL] [Abstract][Full Text] [Related]
14. [Renin inhibition in hypertension].
Güleç S
Turk Kardiyol Dern Ars; 2009 Oct; 37 Suppl 7():15-22. PubMed ID: 20019472
[TBL] [Abstract][Full Text] [Related]
15. Renin inhibition in hypertension.
Gradman AH; Kad R
J Am Coll Cardiol; 2008 Feb; 51(5):519-28. PubMed ID: 18237679
[TBL] [Abstract][Full Text] [Related]
16. Aliskiren, the first direct renin inhibitor for treatment of hypertension: the path of its development.
Jadhav M; Yeola C; Zope G; Nabar A
J Postgrad Med; 2012; 58(1):32-8. PubMed ID: 22387646
[TBL] [Abstract][Full Text] [Related]
17. Safety and efficacy of aliskiren in the treatment of hypertension and associated clinical conditions.
Angeli F; Reboldi G; Mazzotta G; Poltronieri C; Garofoli M; Ramundo E; Biadetti A; Verdecchia P
Curr Drug Saf; 2012 Feb; 7(1):76-85. PubMed ID: 22663961
[TBL] [Abstract][Full Text] [Related]
18. Aliskiren in the management of hypertension.
Barrios V; Escobar C
Am J Cardiovasc Drugs; 2010; 10(6):349-58. PubMed ID: 21090828
[TBL] [Abstract][Full Text] [Related]
19. Direct renin inhibition: an analysis of possible benefits.
Dockery BK; Bisognano JD
Curr Hypertens Rep; 2008 Aug; 10(4):313-8. PubMed ID: 18625162
[TBL] [Abstract][Full Text] [Related]
20. Long-term safety, tolerability and efficacy of aliskiren in combination with valsartan in patients with hypertension: a 6-month interim analysis.
Chrysant SG; Murray AV; Hoppe UC; Dattani D; Patel S; Hsu H; Zhang J
Curr Med Res Opin; 2008 Apr; 24(4):1039-47. PubMed ID: 18307835
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
